| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0003 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0005 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0005 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | KIN001-236 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0007 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.0009 |